Comparison of one-year real-world outcomes between red (670 nm) subthreshold micropulse laser treatment and intravitreal aflibercept injection for treatment-naïve diabetic macular edema

Comparison of one-year real-world outcomes between red (670 nm) subthreshold micropulse laser treatment and intravitreal aflibercept injection for treatment-naïve diabetic macular edema

Purpose: To evaluate the treatment outcomes of subthreshold micropulse laser (SMPL) with a wavelength of 670 nm (red) for treatment-naïve diabetic macular edema (DME). Methods: A retrospective observational study which included 42 eyes in 34 patients diagnosed with treatment-naïve DME was conducted....

Full description

Saved in:
Bibliographic Details
Main Authors: Wataru Kikushima, Yukiko Furuhata, Taiyo Shijo, Mizuki Matsumoto, Yoichi Sakurada, Daphne Viel Tsuru, Kenji Kashiwagi
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Photodiagnosis and Photodynamic Therapy
Subjects:
Treatment-naïve DME
Red SMPL
Anti-VEGF agent
aflibercept, OCTA
Online Access:http://www.sciencedirect.com/science/article/pii/S1572100024004666
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items